Curcumin overcome primary gefitinib resistance in non-small-cell lung cancer cells through inducing autophagy-related cell death-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Curcumin overcome primary gefitinib resistance in non-small-cell lung cancer cells through inducing autophagy-related cell death

Published:2019-06-13 Issue:1 Volume:38 Page:
ISSN:1756-9966
Container-title:Journal of Experimental & Clinical Cancer Research
language:en
Short-container-title:J Exp Clin Cancer Res

Author:

Chen Ping,Huang Han-Peng,Wang Yi,Jin Jun,Long Wei-Guo,Chen Kan,Zhao Xiao-Hui,Chen Chen-Guo,Li Jian

Funder

National Natural Science Foundation of China

Medical Research Program of Jiangsu Health and Family Planning Commission, China

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13046-019-1234-8.pdf

Reference53 articles.

1. Shama SV, Bell DW, Settleman J, Haber DA. Epidermal growth factor receptor mutation in lung cancer. Nat Rev Cancer. 2007;7:169–81.

2. Pao W, Chmielechi J. Rational biologically based treatment of EGFR-mutation non-small-cell lung cancer. Nat Rev Cancer. 2010;10:760–74.

3. Catado VD, Gibbons DL, pérez-Solar R, Quintás-Cardama A. Treatment of non-small-cell lung cancer with erlotinib or gefitinib. N Engl J Med. 2011;64:947–55.

4. Stella GM, Luisetti M, Inghilleri S, Cemmi F, Scabini R, Zorzetfo M, Pozzi E. Targeting EGFR in non-small-cell lung cancer: lessons experiences, strategies. Respir Med. 2012;106:173–83.

5. Kobayashi S, Boggon TJ, Dayaram T, Jänne DA, kocher O, Meyerson M, Jonhnson BE, Eck MJ, Tene DG, Halmos B. EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. N Engl J Med. 2005;352:786–92.

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive landscape analysis of autophagy in cancer development and drug resistance;Frontiers in Immunology;2024-08-26

2. Autophagy: A potential target for natural products in the treatment of ulcerative colitis;Biomedicine & Pharmacotherapy;2024-07

3. Combination of betulinic acid and EGFR-TKIs exerts synergistic anti-tumor effects against wild-type EGFR NSCLC by inducing autophagy-related cell death via EGFR signaling pathway;Respiratory Research;2024-05-20

4. β-Elemene Reverses Gefitinib Resistance in NSCLC Cells by Inhibiting lncRNA H19-Mediated Autophagy;Pharmaceuticals;2024-05-14

5. Synergistic anticancer effects of ginsenoside CK and gefitinib against gefitinib-resistant NSCLC by regulating the balance of angiogenic factors through HIF-1α/VEGF;Toxicology and Applied Pharmacology;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3